NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 316 filers reported holding NOVOCURE LTD in Q4 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $33,900 | -88.1% | 1,979 | -89.6% | 0.00% | -100.0% |
| Q1 2024 | $284,981 | +0.5% | 18,995 | 0.0% | 0.00% | -33.3% |
| Q4 2023 | $283,595 | -7.0% | 18,995 | +0.6% | 0.00% | 0.0% |
| Q3 2023 | $304,831 | -61.1% | 18,875 | 0.0% | 0.00% | -62.5% |
| Q2 2023 | $783,313 | -52.6% | 18,875 | -31.3% | 0.01% | -55.6% |
| Q1 2023 | $1,651,264 | +1111.0% | 27,457 | +1377.0% | 0.02% | +800.0% |
| Q4 2022 | $136,358 | -93.5% | 1,859 | -93.2% | 0.00% | -92.0% |
| Q3 2022 | $2,086,183 | +9.3% | 27,457 | 0.0% | 0.02% | +19.0% |
| Q2 2022 | $1,908,262 | -16.1% | 27,457 | 0.0% | 0.02% | -4.5% |
| Q1 2022 | $2,274,812 | – | 27,457 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |